Nina Nabiha M. Das
Chief Investment Officer | Finance & Commercialization Strategist | Innovation & Growth via M&A | Private Equity | Family Offices | Tech&AI Investing | Healthcare | Nature + Climate + Circularity I Prev. @CDC, World Bank
- Role
- Chief Investment Officer at The Meritage Venture Group
- Location
- Palm Beach, FL, US
- LinkedIn followers
- 500 followers
About Nina Nabiha M. Das
Nina is a multilingual corporate development, commercialization, and strategy executive with a public health, ecosystem & ethical technologist mindset. She has experience co-leading game-changing sustainability, healthcare and digital innovation via novel partnerships and M&A. As a high-level fiduciary, launch expert, and evidence-informed evaluator, she is known for her servant and collaborative leadership style. Nina delivers specialized strategic roadmaps, nuanced deal origination, negotiations, complex due diligence, with exceptional closing and integration acumen for value-creation and impact. At The Meritage Venture Group, Nina leads Series A/B+ tech impact investments for planetary & human health as CIO and Investment Committee Chair. At Mindful M&A, Nina provides finance and innovation strategies, including tech scouting and in sustainability, healthcare, and aesthetics. At Viper Equity Partners, Nina directed the Aesthetics and Healthcare M&A Transactions Division, closing middle-market rollups and add-ons in specialty dental, dermatology and aesthetics backed by PE & Family Offices. At Transworld M&A, Nina orchestrated proprietary buy- and sell-side M&A in fraud detection,(aero)space, regenerative ag, circularity, healthcare SaaS/A and clinical service consolidations. At Take5, Nina led multicultural digital marketing for sustainable CPG & wellness brands. At BioDiVie, Nina led diverse M&A, go-to-market, evaluation and digital transformation teams in global health, sustainability, 3DP, & SaaS verticals, partnering with Fortune 100 strategics, Coulter and Ford Foundations, and the CDC. She pioneered biodiversity mainstreaming, ecosystem services, sustainable livelihoods finance & safeguards at The World Bank and IUCN, as well as growth strategies for stellar startups: VIS (eyes), Rion & Cynosure (aesthetics), DDM (3DP), NexMed (diabetes/cardio), Polaris Surgical (spine) & EndoChoice (GI). Her passion is to be value-add and co-create resilience & wellness, inclusively. Industries: Aesthetics • AI • Biodiversity • Digital Imaging • 3DP • Genomics • Global Health & Infectious Disease Prevention • Medical Devices • SaaS • Renewables • Forestry • Organic/Regenerative Agriculture • Biologics/Biomaterials • SustainabilityExpertise: Strategy • Corporate Development • Proprietary M&A • Due Diligence • Partnerships, JVs, JDAs & Alliances • FP & A • Risk-Adjusted Valuation • Negotiation • Tech/IP Scouting • Design-Thinking • Product Launch • Pricing • Multi-Channel Marketing • Lean Ops • M&E • Stakeholder Engagement • Global Commercialization
Experience
Chief Investment Officer
Apr 2022 — Present
Education
Yale School of the Environment
Exchange Scholar --- Agroforestry, Forest Conservation and Restoration, Political Ecology
1995
Emory University - Goizueta Business School
Executive MBA (Distinction), Corporate Finance, Strategy, Marketing & Business of Healthcare
St. Stephen's Episcopal School
Bishop's Medal for Highest Academic Honors for All High School Years
University of Michigan
MA Anthropology and History
University of California, Berkeley
MSc Forest and Coastal Ecosystem Dynamics, Monitoring & Conservation
McGill University
BEng. Concentration: Electrical/Biomedical Engineering & Global Environmental Studies Minor
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.